Abstract
High throughput sequencing technology has opened a window into the vast communities of bacteria that live on and in humans, demonstrating tremendous variability, and that they play a large role in health and disease. The eukaryotic component of the human gut microbiome remains relatively unexplored with these methods, but turning these tools toward microbial eukaryotes in the gut will likely yield myriad insights into disease as well as the ecological and evolutionary principles that govern the gut microbiota. Microbial eukaryotes are common inhabitants of the human gut worldwide and parasitic taxa are a major source of morbidity and mortality, especially in developing countries, though there are also taxa that cause no harm or are beneficial. While the role microbial eukaryotes play in healthy individuals is much less clear, there are likely many complex interactions between the bacterial, archaeal, and eukaryotic microbiota that influence human health. Integrating eukaryotic microbes into a broad view of microbiome function requires an integrated ecological approach rather than one focused on specific, disease-causing taxa. Moving forward, we expect broad surveys of the eukaryotic microbiota and associated bacteria from geographically and socioeconomically diverse populations to paint a more complete picture of the human gut microbiome in health and disease.
Introduction
Microbial eukaryotes are an important component of the human gut microbiome. Eukaryotes that reside in the human gut are distributed across the eukaryotic tree (Figure 1) and their relationship with the human host varies from parasitic to opportunistic to commensal to mutualistic. For the purposes of this review, we are focusing on the microbial eukaryotes and are not discussing metazoan parasites, which are thoroughly covered elsewhere (Stoll, ; Kassai, ; Muller, ; Bogitsh et al., ). We are also focusing on the gut microbiome as many eukaryotic microbes are found there, and it is the best-characterized human body site in terms of the bacterial communities.
Figure 1
Eukaryotes are one of the three domains of life and are defined by the presence of nuclei. Animals, plants, and fungi are the most visible clades of eukaryotes, but these are just three of the 70+ lineages (Patterson,
Approaches to Studying Host-Associated Microbial Eukaryotes
Microbial eukaryotes in the human gut have been studied primarily from a parasitological point of view and are generally considered to negatively impact human health. The methods typically used focus on elucidating the presence of specific parasitic taxa, traditionally with culture and microscopy-based approaches (Bogitsh et al.,
In recent years barcoded high throughput sequencing of marker genes like small subunit ribosomal DNA (Hamady et al.,
There is growing body of theoretical and experimental literature on co-infection within the infectious disease community that stresses the importance of considering the action of disease agents within the context of other microbial players (e.g., Cox,
Roles of Host-Associated Eukaryotes: Pathogen, Commensal, Beneficial
Understanding the prevalence and distribution of microbial eukaryotes in the human gut has large consequences for human health. This is especially true in the developing world, where microbial parasites represent a large source of morbidity and mortality (Kaplan et al.,
While the focus is generally on pathogens (in terms of study effort, genome sequencing, etc.), most microbial eukaryotes that reside in the gut do not cause harm, being either beneficial or commensal. Some eukaryotic microbes are considered probiotics, in particular the yeast Saccharomyces boulardii was originally isolated to combat Cholera, and it now marketed as a cure for diarrhea (McFarland and Bernasconi,
Human-associated microbial eukaryotes found in the gut are the focus of this article; however, eukaryotes are also part of the microbial community in other locations of the human microbiome. There is a low-diversity fungal community associated with human skin dominated by the genus Malassezia (Paulino et al.,
Current Surveys of the Eukaryotic Component of the Human Microbiome
Comprehensive study of the eukaryotic component of the human microbiome is just beginning and lags far behind our understanding of the bacterial communities. Initial CI surveys that were done with low-throughput methods of community finger printing and clone library sequencing are intriguing and suggest that there are numerous parallels between the bacterial and eukaryotic components of the microbiome. Fungi and Blastocystis are the dominant (and in many cases the only) eukaryotes in the gut microbiome of healthy individuals (Nam et al.,
Evolutionary Context
The evolutionary patterns of microbial diversity within the vertebrate gut are similar across eukaryotes, bacteria, and archaea. Across all taxa only a small number of lineages have adapted to the gut environments, but those lineages are successful in colonizing a wide variety of hosts. Reduced diversity at deep phylogenetic levels (e.g., the Bacteroidetes and Firmicutes divisions of bacteria) is a hallmark of host-associated bacteria and archaea (Ley et al.,
The common patterns of diversity in the gut microbiome seen across the three domains of life are likely driven by the fact that host-associated environments, and especially the gut, are unique microbial habitats that are difficult to colonize because the stable, warm, low-oxygen, and eutrophic conditions represent an extreme environment (Ley et al.,
Eukaryotic Communities in Other Hosts
The eukaryotic microbiota has been extensively studied in animals where eukaryotes play a more central role, such as ruminants and termites, and these studies may provide expectations for the role of eukaryotes in the human microbiome. Culture independent studies have shown that mice harbor fungal communities that are much more diverse than those found in humans (Scupham et al.,
Examining the eukaryotic microbiota associated with diverse animals has the potential to reveal new lineages of eukaryotes as several clades are known only from the microbiome of specific taxa. For example opalinids, a clade of stramenopiles, are only found in the hindgut of amphibians and hypermastigid parabasalids in the hindguts of termites and cockroaches. Parasites of invertebrate animals are more broadly distributed across the eukaryotic tree (Orange branches in Figure 1), and several novel lineages have been recently discovered (e.g., Hertel et al.,
The Ecological Context of the Gut Microbiome
The species composition and general patterns of diversity found in the intestinal microbiota are best understood from an ecological perspective (reviewed in Ley et al.,
The range of the host response to many individual microbial eukaryotes varies greatly from asymptomatic to causing morbidity or mortality. For example, many people infected with known parasites, such as E. histolytica and G. intestinalis, are asymptomatic (Prado et al.,
Opportunistic parasites are a significant source of morbidity in immune compromised patients, although these same taxa may be present in healthy people without apparent consequence. These emerging opportunistic pathogens include Cryptosporidium parvum, Pneumocystis carnii, and microsporidia, and all generally cause severe diarrhea (Kaplan et al.,
Eukaryotes have also been implicated as causative agents of diseases such as IBS (Blastocystis), IBD (fungi), and “leaky gut” (Candida; Boorom et al.,
Several eukaryotic parasites are thought to interact with malnutrition and increase morbidity in parts of the developing world. For example, children infected with Giardia may experience reduced growth even when the infection is asymptomatic (Prado et al.,
Prospects for the Future
Incorporation of eukaryotes into human microbiome studies is just beginning, and will benefit from broad CI surveys of the eukaryotic communities in healthy and diseased individuals. These surveys should encompass diverse populations of healthy and diseased individuals, and should exploit within-subject time-series designs (to control for inter-individual diversity of the microbiome), and use identical twins (to control for genetic variability). Analyzing these data with emerging computational tools, such as co-occurrence networks, and pipelines for comparing large numbers of samples (Caporaso et al.,
Statements
Acknowledgments
Many thanks to Valerie McKenzie and members of the Knight lab for comments on the manuscript, especially Catherine Lozupone, Jesse Zaneveld, Justin Kuczynski, and Daniel McDonald. This manuscript was improved following comments from two reviewers. Support from the Bill and Melinda Gates Foundation, the Crohn’s and Colitis Foundation of America, the National institutes of Health, and the Howard Hughes Medical Institute is acknowledged.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AdlS. M.SimpsonA. G. B.FarmerM. A.AndersenR. A.AndersonO. R.BartaJ. R.BowserS. S.BrugerolleG.FensomeR. A.FredericqS.JamesT. Y.KarpovS.KugrensP.KrugJ.LaneC. E.LewisL. A.LodgeJ.LynnD. H.MannD. G.McCourtR. M.MendozaL.MoestrupO.Mozley-StandridgeS. E.NeradT. A.ShearerC. A.SmirnovA. V.SpiegelF. W.TaylorM. (2005). The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. J. Eukaryot. Microbiol.52, 399–451.10.1111/j.1550-7408.2005.00053.x
2
BarnardS.UptonS. (l994). A Vetrinary Guide to the Parasites of Reptiles.Malabar, FL: Krieger Publishing Company.
3
BogitshB.CarterC.OeltmannT. (2005). Human Parasitology.Amsterdam: Elsevier.
4
BooromK. F.SmithH.NimriL.ViscogliosiE.SpanakosG.ParkarU.LiL. H.ZhouX. N.OkU. Z.LeelayoovaS.JonesM. S. (2008). Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit. Vectors1, 40.10.1186/1756-3305-1-40
5
BurkiF.KudryavtsevA.MatzM. V.AglyamovaG. V.BulmanS.FiersM.KeelingP. J.PawlowskiJ. (2010). Evolution of Rhizaria: new insights from phylogenomic analysis of uncultivated protists. BMC Evol. Biol.10, 377.10.1186/1471-2148-10-377
6
CaporasoJ. G.KuczynskiJ.StombaughJ.BittingerK.BushmanF. D.CostelloE. K.FiererN.PenaA. G.GoodrichJ. K.GordonJ. I.HuttleyG. A.KelleyS. T.KnightsD.KoenigJ. E.LeyR. E.LozuponeC. A.McDonaldD.MueggeB. D.PirrungM.ReederJ.SevinskyJ. R.TumbaughP. J.WaltersW. A.WidmannJ.YatsunenkoT.ZaneveldJ.KnightR. (2010). Qiime allows analysis of high-throughput community sequencing data. Nat. Methods7, 335–336.10.1038/nmeth.f.303
7
CaronD. A.WordenA. Z.CountwayP. D.DemirE.HeidelbergK. B. (2009). Protists are microbes too: a perspective. ISME J.3, 4–12.10.1038/ismej.2008.101
8
CarpenterK. J.ChowL.KeelingP. J. (2009). Morphology, phylogeny, and diversity of Trichonympha (Parabasalia: Hypermastigida) of the wood-feeding cockroach Cryptocercus punctulatus. J. Eukaryot. Microbiol.56, 305–313.10.1038/ismej.2008.101
9
ChurchC.NeillA.SchotthoeferA. M. (2010). Intestinal infections in humans in the rocky mountain region, United States. J. Parasitol.96, 194–196.10.1645/GE-2229
10
CostelloE. K.LauberC. L.HamadyM.FiererN.GordonJ. I.KnightR. (2009). Bacterial community variation in human body habitats across space and time. Science326, 1694–1697.10.1126/science.1177486
11
CoxF. E. (2001). Concomitant infections, parasites and immune responses. Parasitology122(Suppl.), S23–S38.10.1017/S003118200001698X
12
FalconeF. H.PritchardD. I. (2005). Parasite role reversal: worms on trial. Trends Parasitol.21, 157–160.10.1016/j.pt.2005.02.002
13
GhannoumM. A.JurevicR. J.MukherjeeP. K.CuiF.SikaroodiM.NaqviA.GillevetP. M. (2010). Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog.6, e1000713.10.1371/journal.ppat.1000713
14
GianoulisT. A.RaesJ.PatelP. V.BjornsonR.KorbelJ. O.LetunicI.YamadaT.PaccanaroA.JensenL. J.SnyderM.BorkP.GersteinM. B. (2009). Quantifying environmental adaptation of metabolic pathways in metagenomics. Proc. Natl. Acad. Sci. U.S.A.106, 1374–1379.10.1073/pnas.0808022106
15
GrahamA. (2008). Ecological rules governing helminth–microparasite coinfection. Proc. Natl. Acad. Sci. U.S.A.105, 566–570.10.1073/pnas.0707221105
16
HamadyM.WalkerJ. J.HarrisJ. K.GoldN. J.KnightR. (2008). Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat. Methods5, 235–237.10.1038/nmeth.1184
17
HaqueR. (2007). Human intestinal parasites. J. Health Popul. Nutr.25, 387–391.
18
HertelL. A.BayneC. J.LokerE. S. (2002). The symbiont Capsaspora owczarzaki, nov gen. Nov sp., isolated from three strains of the pulmonate snail biomphalaria glabrata is related to members of the mesomycetozoea. Int. J. Parasit.32, 1183–1191.10.1016/S0020-7519(02)00066-8
19
HeywoodJ.SierackiM.BellowsW.PoultonN.StepanauskasR. (2011). Capturing diversity of marine heterotrophic protists: one cell at a time. ISME J.2011, 674–684.10.1038/ismej.2010.155
20
HjortK.GoldbergA. V.TsaousisA. D.HirtR. P.EmbleyT. M. (2010). Diversity and reductive evolution of mitochondria among microbial eukaryotes. Philos. Trans. R. Soc. B Biol. Sci.365, 713–727.10.1098/rstb.2009.0224
21
IrbisC.UshidaK. (2004). Detection of methanogens and proteobacteria from a single cell of rumen ciliate protozoa. J. Gen. Appl. Microbiol.50, 203–212.10.2323/jgam.50.203
22
KaplanJ. E.JonesJ. L.DykewiczC. A. (2000). Protists as opportunistic pathogens: public health impact in the 1990s and beyond. J. Eukaryot. Microbiol.47, 15–20.10.1111/j.1550-7408.2000.tb00004.x
23
KassaiT. (1999). Veterinary Helminthology.Oxford: Butterworth-Heinemann.
24
KeelingP. J.BurgerG.DurnfordD. G.LangB. F.LeeR. W.PearlmanR. E.RogerA. J.GrayM. W. (2005). The tree of eukaryotes. Trends Ecol. Evol.20, 670–676.10.1016/j.tree.2005.09.005
25
KreierJ.BakerJ. (1987). Parasitic Protozoa. Boston: Allen and Unwin, Inc.
26
LaffertyK. D. (2010). Interacting parasites. Science330, 187–188.10.1126/science.1196915
27
LeyR. E.LozuponeC. A.HamadyM.KnightR.GordonJ. I. (2008). Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol.6, 776–788.10.1038/nrmicro1978
28
LeyR. E.PetersonD. A.GordonJ. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell124, 837–848.10.1016/j.cell.2006.02.017
29
MarchesiJ. R. (2010). Prokaryotic and eukaryotic diversity of the human gut. Adv. Appl. Microbiol.72, 43–62.
30
MargulisL.CorlissJ. O.MelkonianM.ChapmanD. J. (eds.) (1990). Handbook of Protoctista. The Jones and Bartlett Series in Life Sciences. Boston: Jones and Bartlett.
31
McFarlandL.BernasconiP. (1993). Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb. Ecol. Health Dis.6, 157–171.
32
MullerR. (2002). Worms and Human Disease.New York, NY: CABI Publishing.
33
NamY. D.ChangH. W.KimK. H.RohS. W.KimM. S.JungM. J.LeeS. W.KimJ. Y.YoonJ. H.BaeJ. W. (2008). Bacterial, archaeal, and eukaryal diversity in the intestines of Korean people. J. Microbiol.46, 491–501.10.1007/s12275-008-0199-7
34
OttS. J.KuhbacherT.MusfeldtM.RosenstielP.HellmigS.RehmanA.DrewsO.WeichertW.TimmisK. N.SchreiberS. (2008). Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol.43, 831–841.10.1080/00365520801935434
35
PaceN. R. (1997). A molecular view of microbial diversity and the biosphere. Science276, 734–740.10.1126/science.276.5313.734
36
ParfreyL. W.GrantJ.TekleY. I.Lasek-NesselquistE.MorrisonH. G.SoginM. L.PattersonD. J.KatzL. A. (2010). Broadly sampled multigene analyses yield a well-resolved eukaryotic tree of life. Syst. Biol.59, 518–533.10.1093/sysbio/syq037
37
ParkarU.TraubR. J.VitaliS.ElliotA.LeveckeB.RobertsonI.GeurdenT.SteeleJ.DrakeB.ThompsonR. C. A. (2010). Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. Vet. Parasitol.169, 8–17.10.1016/j.vetpar.2009.12.032
38
PattersonD. J. (1999). The diversity of eukaryotes. Am. Nat.154, S96–S124.10.1086/303287
39
PaulinoL. C.TsengC. H.StroberB. E.BlaserM. J. (2006). Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol.44, 2933–2941.10.1128/JCM.00785-06
40
PetersonD. A.FrankD. N.PaceN. R.GordonJ. I. (2008). Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe3, 417–427.10.1016/j.chom.2008.05.001
41
PradoM. S.CairncrossS.StrinaA.BarretoM. L.Oliveira-AssisA. M.RegoS. (2005). Asymptomatic giardiasis and growth in young children; a longitudinal study in Salvador, Brazil. Parasitology131, 51–56.10.1017/S0031182005007353
42
PrittB.ClarkC. G. (2008). Amebiasis. Mayo Clin. Proc.83, 1154–1160.10.4065/83.10.1154
43
RadekR. (1999). Flagellates, bacteria, and fungi associated with termites: diversity and function in nutrition - a review. Ecotropica5, 183–196.
44
RobinsonC. J.BohannanB. J. M.YoungV. B. (2010). From structure to function: the ecology of host-associated microbial communities. Microbiol. Mol. Biol. Rev.74, 453–476.10.1128/MMBR.00014-10
45
ScanlanP. D.MarchesiJ. R. (2008). Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J.2, 1183–1193.10.1038/ismej.2008.76
46
SchulzeJ.SonnenbornU. (2009). Yeasts in the gut: from commensals to infectious agents. Dtsch. Arztebl. Int.106, 837–841.
47
SchusterF. L.Ramirez-AvilaL. (2008). Current world status of Balantidium coli. Clin. Microbiol. Rev.21, 626–638.
48
ScuphamA. J.PresleyL. L.WeiB.BentE.GriffithN.McPhersonM.ZhuF. L.OluwadaraO.RaoN.BraunJ.BornemanJ. (2006). Abundant and diverse fungal microbiota in the murine intestine. Appl. Environ. Microbiol.72, 793–801.10.1128/AEM.72.1.793-801.2006
49
SteeleJ.CountwayP. D.XiaL.VigilP.BemanJ.KimD.ChowC.SachdevaR.JonesA.SchwalbachM.RoseJ.HewsonI.PatelA.SunF.CaronD.FuhrmanJ. (2011). Marine bacterial, archaeal and protistan association networks reveal ecological linkages. ISME J.1–12.10.1128/AEM.72.1.793-801.2006
50
StensvoldC. R.LebbadM.VerweijJ. J. (2011). The impact of genetic diversity in protozoa on molecular diagnostics. Trends Parasitol.27, 53–58.10.1016/j.pt.2010.11.005
51
StollN. R. (1947). This wormy world. J. Parasitol.33, 1–18.10.2307/3273478
52
SwidsinskiA.Loening-BauckeV.HerberA. (2009). Mucosal flora in crohn’s disease and ulcerative colitis – an overview. J. Physiol. Pharmacol.60, 61–71.
53
TelferS.LambinX.BirtlesR.BeldomenicoP.BurtheS.PatersonS.BegonM. (2010). Species interactions in a parasite community drive infection risk in a wildlife population. Science330, 243–246.10.1126/science.1190333
54
WalkS.YoungV. (2008). Emerging insights into antibiotic-associated diarrhea and Clostridium difficile infection through the lens of microbial ecology. Interdiscip. Perspect. Infect. Dis. 2008, 7.
55
WhittakerR. H. (1969). New concepts of kingdoms of organisms. Science163, 150–160.10.1126/science.163.3863.150
56
WildschutteH.WolfeD. M.TamewitzA.LawrenceJ. G. (2004). Protozoan predation, diversifying selection, and the evolution of antigenic diversity in Salmonella. Proc. Natl. Acad. Sci. U.S.A.101, 10644–10649.
57
WilliamsA.ColemanG. (1992). The Rumen Protozoa.New York: Springer-Verlag.
58
YoonH. S.PriceD. C.StepanauskasR.RajahV. D.SierackiM. E.WilsonW. H.YangE. C.DuffyS.BhattacharyaD. (2011). Single-cell genomics reveals organismal interactions in uncultivated marine protists. Science332, 714–717.10.1126/science.1203163
Summary
Keywords
intestinal protozoa, host-associated communities, eukaryotic diversity
Citation
Parfrey LW, Walters WA and Knight R (2011) Microbial Eukaryotes in the Human Microbiome: Ecology, Evolution, and Future Directions. Front. Microbio. 2:153. doi: 10.3389/fmicb.2011.00153
Received
02 April 2011
Accepted
28 June 2011
Published
11 July 2011
Volume
2 - 2011
Edited by
Peter J. Turnbaugh, Harvard University, USA
Reviewed by
Alain Stintzi, Ottawa Institute of Systems Biology, Canada; Jacques Ravel, University of Maryland School of Medicine, USA
Copyright
© 2011 Parfrey, Walters and Knight.
This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
*Correspondence: Rob Knight, Department of Chemistry and Biochemistry, University of Colorado, UCB 215, Boulder, CO 80309, USA. e-mail: rob.knight@colorado.edu
This article was submitted to Frontiers in Cellular and Infection Microbiology, a specialty of Frontiers in Microbiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.